109 Therapeutics, Inc. — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for 109 Therapeutics, Inc., built entirely from public federal award records. Free competitive intelligence — no login required.
- 2 awards
- $518,889 total on record
- 2 agencies
- 2 Phase I · 0 Phase II
Phase mix
- Phase I — 2 awards
Funding agencies
Awards by year
- 2021 — 1 award
- 2020 — 1 award
Places of performance
Firms like 109 Therapeutics, Inc.
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 1R43GM142413-01A1 | Department of Health and Human Services | $263,051 | SBIR · Phase I | 2021-09-30 |
| 2026176 | National Science Foundation | $255,838 | SBIR · Phase I | 2020-09-01 |
Frequently asked questions
How many SBIR/STTR awards has 109 Therapeutics, Inc. won?
109 Therapeutics, Inc. has won 2 SBIR/STTR awards worth $518,889 in the public federal award records SBIR Signal tracks, including 2 Phase I and 0 Phase II award(s).
Which agencies fund 109 Therapeutics, Inc.?
109 Therapeutics, Inc.'s awards come from 2 agencies on record; its top funder is Department of Health and Human Services.
What technology areas does 109 Therapeutics, Inc. work in?
Based on its award history, 109 Therapeutics, Inc. works in a range of technology areas.
How do I find firms similar to 109 Therapeutics, Inc.?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.